论文部分内容阅读
柳胺苄心定(Labetalol)兼有α-肾上腺素能受体和β-肾上腺素能受体阻滞作用,可用于治疗高血压和心绞痛.对于心绞痛患者,柳胺苄心定能降低心肌的氧需量,减小心率-血压的乘积,从而使患者的运动耐量得以改善.在动物实验中,柳胺苄心定能使冠状动脉的血流增加.然而,有关其对人类冠状动脉血流的作用尚未有报道.本文旨在评价柳胺苄心定在冠心病患者中的血流动力学和冠状动脉效应.
Labetalol is a combination of alpha-adrenergic receptor and beta-adrenergic receptor blockade for the treatment of hypertension and angina pectoris. For patients with angina pectoris, Oxygen demand, reduce the heart rate - the product of blood pressure, so that patients with exercise tolerance can be improved in animal experiments, liufen benzyl clonidine can make the coronary blood flow increased.However, its on human coronary blood flow Has not yet been reported.This article aims to evaluate the hemodynamics and coronary effects of salidroside in patients with coronary heart disease.